| 发明名称 |
TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY |
| 摘要 |
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide. |
| 申请公布号 |
US2017028026(A1) |
申请公布日期 |
2017.02.02 |
| 申请号 |
US201615286252 |
申请日期 |
2016.10.05 |
| 申请人 |
NPS Pharmaceuticals, Inc. |
发明人 |
Sanguinetti Elizabeth L.;Marriott Thomas B.;Lopansri Jennifer;Blosch Consuelo M. |
| 分类号 |
A61K38/26;A61K9/00 |
主分类号 |
A61K38/26 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of increasing urine weight of a patient having short bowel syndrome, who receives an amount of parenteral nutrition each week, and who presents with colon-in-continuity with remnant small intestine, said method comprising administering h(Gly2)GLP-2 receptor agonist to said patient using a dosing regimen effective to increase the urine weight of said patient. |
| 地址 |
Bedminster NJ US |
